Mediacom world news portal
ASTRAZENECA has struck a deal worth up to $ 400 million with Japan’s Takeda Pharmaceutical to co-develop and commercialise a potential treatment for Parkinson’s disease.
Daily Express :: City and Business Feed
ASTRAZENECA has struck a deal worth up to $ 400 million with Japan’s Takeda Pharmaceutical to co-develop and commercialise a potential treatment for Parkinson’s disease.
Daily Express :: City and Business Feed